MIA researchers feature on prestigious Highly Cited Researchers 2021 List
19 November 2021
Melanoma Institute Australia is proud to announce that MIA’s Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, as well as MIA Faculty members Associate Professor Alex Menzies and Associate Professor Matt Carlino, and former Faculty member Professor Rick Kefford AM, have all been named on the annual Highly Cited Researchers™ 2021 list from Clarivate.
The highly anticipated annual list is the “who’s who” of the scientific elite from across the globe. It identifies the ‘One in 1,000’ Citation Elite – the researchers who demonstrated significant influence in their chosen field or fields through the publication of multiple highly cited papers during the last decade. Their names are drawn from the publications that rank in the top 1% by citations for field and publication year in the Web of Science™ citation index.
According to Clarivate, 6,602 researchers from more than 70 countries and regions have been recognized this year. Australia has narrowly overtaken Germany to come in fourth, with 332 researchers making the list- remarkable for a country of 25 million compared with Germany’s 83 million.
David Pendlebury, Senior Citation Analyst at the Institute for Scientific Information at Clarivate said:
‘It is increasingly important for nations and institutions to recognize and support the exceptional researchers who are driving the expansion of the world’s knowledge. This list identifies and celebrates exceptional individual researchers at Melanoma Institute Australia who are having a significant impact on the research community as evidenced by the rate at which their work is being cited by their peers. The research they have contributed is fuelling the innovation, sustainability, health and security that is key for our society’s future.’
Melanoma Institute Australia CEO Matthew Browne said the inclusion of four current members of MIA’s Faculty on the global list for the second year running was indicative of our standing on the world stage.
‘To have MIA researchers feature so prominently in the ‘who’s who’ of the world’s scientific elite shows the life-changing impact of our work not only in Australia but internationally,’ he said. ‘Under the leadership of our Co-Medical Directors, Professor Georgina Long AO and Professor Richard Scolyer AO, MIA continues to reach new heights and spearhead the world towards a cure for not only melanoma, but increasingly other complex skin cancers as well. On behalf of the entire MIA team, and our patients, their families and our wonderfully supportive community and donors, I extend my heartfelt congratulations to our four Faculty members named on the Highly Cited Researchers list.’
The full 2021 Highly Cited Researchers list and executive summary can be found online here.
Melanoma Institute Australia is affiliated with The University of Sydney
Congratulations to Professor Richard Scolyer who was awarded the William O. Russell/Joanne Vandenberge Hill Award of Excellence in Pathology.
A Day in the Life Of... Serigne Lo, Research and BioStatistics Manager at Melanoma Institute Australia
Jay was your typical Aussie bloke – a truck driver, husband, dad and mate to many. Then he got melanoma. His cancer diagnosis turned his life upside down.
Clair faced an impossible choice – risk delivering her baby early, or delay potentially life-saving melanoma treatment
Little Madi misses her Dad. But she is determined to honour his memory and support life-saving melanoma research.
Toyota and country music fans invited to tip their hat to help tackle Australia's national cancer – melanoma
Melanoma Institute Australia has teamed up with the Toyota Country Music Festival 2018 in Tamworth!
MIA's dermatologist shares her knowledge with GPs on debunking myths and controversies on sunscreen.
Shannan Ponton thought he was invincible – he wasn’t. But his melanoma battle ended up saving more than his own life.
Researchers have demonstrated that immunotherapy is highly effective in treating a rare form of melanoma – a result that is surprising due to the nature of the tumour.
Innovation is helping to prevent melanoma developing in the first place.
Research from MIA is changing the way melanoma is managed worldwide and improving patient survival. Here are a few of our key highlights from this year.
A prestigious Fellowship has been awarded to fund research that will change the way melanoma treatment is assessed in the future.
New research from MIA has been published that forms the basis of the updated international guidelines for staging melanoma.
Professor William McCarthy AM has been awarded the Tom Reeve Award for Outstanding Contributions to Cancer Care.
Leading researchers from MIA have been acknowledged with three prestigious awards for excellence in melanoma research.
New research shows that patients who are more likely to respond to immunotherapy treatment have a greater diversity in their gut bacteria.
2018 will be bigger than ever, and a little bit different.
MIA's epidemiologist explains her new research on how country of residence should be considered when identifying melanoma risk.
Congratulations to our Conjoint Medical Directors, Professor Georgina Long and Professor Richard Scolyer, who have today been announced as Fellows of the Australian Academy of Health and Medical Sciences.
New research shows potentially deadly UV damage can appear decades earlier than you think.